Quote:
Originally Posted by Natalie8
This article came out yesterday. Very interesting -- I've never heard of this drug--efalizumab for psoriasis. About 46,000 people are on it worldwide. 3 PML cases (2 recent) causing concern. After 3 years on the drug the risk of getting PML is 1:1100. Some doctors are now calling for people to get off it because they don't view that as a risk worth taking.
http://www.medpagetoday.com/MeetingCoverage/SDEF/12849 |
Efalizumab is another one of the monoclonal antibody drugs that has surfaced in the last number of years. These drugs play with the immune system and as we very well know, contracting PML is a nasty side effect.
I'm guessing one would have to think long and hard about using this kind of drug for something like psoriasis, especially after these recent PML cases.
Harry